-- 根据周一提交给澳大利亚证券交易所的文件，Cynata Therapeutics（ASX：CYP）已获得约600万股普通股的认购承诺，每股定价0.25澳元，总募集资金约150万澳元。 该公司计划将募集资金用于潜在的商业合作，此前该公司预计将分别于5月和6月公布其骨关节炎和急性移植物抗宿主病临床试验的结果。 该公司表示，此次“战略规模”的配售有助于公司在结果公布后增强现金储备，同时最大限度地减少股权稀释。 Cynata Therapeutics股价在周一的交易中下跌了4%。
Related Articles
Asia
SML Mahindra's April Sales Rise 15% to 1,741 Units
Automobile manufacturer SML Mahindra's (NSE:SMLMAH, BOM:505192) total sales rose 15% to 1,741 units in April from 1,512 units sold a year ago, according to a Friday filing to the Indian stock exchanges.Passenger vehicle sales were up 19% year on year in the reported month to 1,331 units, while cargo vehicle sales rose 5% to 410 units.
$BOM:505192$NSE:SMLMAH
Asia
Atul Auto's Sales Rise 74% in April
Three-wheeler manufacturer Atul Auto's (NSE:ATULAUTO, BOM:531795) total sales jumped 74% to 3,001 units in April from 1,725 units sold a year ago, according to a Friday filing to the Indian stock exchanges.Of the total, domestic sales grew sharply year-on-year to 2,478 units in April from 1,427 units.
$BOM:531795$NSE:ATULAUTO
Asia
Leader Education's Fiscal H1 Profit Falls 17%
Leader Education (HKG:1449) booked 20.2 million yuan in attributable profit for the fiscal first half ended Feb. 28, down 17% from 24.2 million yuan a year earlier, according to a Hong Kong bourse filing Sunday.The higher education services company's shares fell nearly 2% in morning trade Monday.Earnings per share were 0.0303 yuan, compared with 0.0363 yuan in the prior-year period.Revenue rose 11% year on year to 191.3 million yuan, figures showed.
$HKG:1449